LondonA fluorinated molecule restored fosfomycin against resistant bacteria.
The compound hijacks UhpT, a bacterial glucose channel, forcing fosfomycin inside resistant cells — 128-fold potency boost in E. coli, the study found.
Fosfomycin is off-patent; reviving existing drugs costs less than developing new antibiotics for global deployment.
Sources: Nature